Drugs / EE001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06884111 | Jun → Dec 2024 | heart failure | Anhui HygeianCells BioMedical Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EE001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06884111 ↗ |
| Route | Intravenous | “70-105ml per day by IV” NCT06884111 ↗ |